OR WAIT null SECS
© 2022 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
One surgeon's preference for an ophthalmic viscosurgical device of 1.6% sodium hyaluronate was reinforced by a study that found it superior to another OVD during phaco and OVD removal